0001209191-13-026037.txt : 20130514 0001209191-13-026037.hdr.sgml : 20130514 20130514110221 ACCESSION NUMBER: 0001209191-13-026037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130510 FILED AS OF DATE: 20130514 DATE AS OF CHANGE: 20130514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Banham John Michael Middlecott CENTRAL INDEX KEY: 0001357635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13908 FILM NUMBER: 13839918 MAIL ADDRESS: STREET 1: C/O CYCLACEL PHARMACEUTICALS, INC. STREET 2: 200 CONNELL DRIVE, SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invesco Ltd. CENTRAL INDEX KEY: 0000914208 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 980557567 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-892-0896 MAIL ADDRESS: STREET 1: 1555 PEACHTREE STREET NE STREET 2: SUITE 1800 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd DATE OF NAME CHANGE: 20080508 FORMER COMPANY: FORMER CONFORMED NAME: Invesco PLC DATE OF NAME CHANGE: 20080429 FORMER COMPANY: FORMER CONFORMED NAME: Invesco Ltd. DATE OF NAME CHANGE: 20071205 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-05-10 0 0000914208 Invesco Ltd. IVZ 0001357635 Banham John Michael Middlecott 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 1 0 0 0 Common Shares 2013-05-10 4 S 0 8500 33.7208 D 20946 D The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average sale price. The range of prices for such transaction was $33.720 to $33.722. /s/ Jonathan J. Doyle, as Attorney in Fact 2013-05-14